KEYTHA THOMPSON: Open Payments
NPI 1538593538 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 18 payments from 8 companies in 2025. Trend: 2023 $535 · 2024 $704 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Dexcom, Inc. | 2 | $47 |
| Exact Sciences Corporation | 2 | $35 |
| Lilly USA, LLC | 1 | $16 |
Products named: LEQVIO, Kerendia, TRELEGY ELLIPTA, BREZTRI, Dexcom G6 Transmitter, Cologuard Collection Kit, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across LA — which companies pay providers there.
